ANCA-Positive Vasculitis with Renal Involvement: Pathologic Findings
In a patient with ANCA-positive vasculitis and renal involvement, you will find necrosis and crescent formations on renal biopsy (option d), which is the hallmark pathologic finding of pauci-immune necrotizing and crescentic glomerulonephritis (NCGN).
Key Pathologic Features
According to the 2024 KDIGO guidelines, the kidney lesion associated with ANCA-associated vasculitis (AAV) is a pauci-immune focal and segmental necrotizing and crescentic glomerulonephritis 1. This is characterized by:
- Necrotizing inflammation of small vessels (arterioles, capillaries, venules)
- Crescent formations in glomeruli
- Little or no deposition of immune complexes in the vessel wall (pauci-immune pattern)
The histopathologic classification system divides ANCA-associated glomerulonephritis based on the predominant glomerular lesion: focal class (≥50% normal glomeruli), crescentic class (≥50% cellular crescents), sclerotic class (≥50% globally sclerotic glomeruli), or mixed class 1.
Why the Other Options Are Incorrect
Option a) Linear IgG deposition along basement membrane - This finding is characteristic of anti-GBM disease (formerly Goodpasture's syndrome), not ANCA-associated vasculitis. The guidelines explicitly distinguish these entities, noting that positive anti-GBM antibodies suggest anti-GBM disease requiring urgent plasma exchange 1.
Option b) Diffuse mesangial IgA deposits - This describes IgA nephropathy, not ANCA vasculitis. ANCA-associated vasculitis is specifically characterized by pauci-immune (minimal immune complex deposition) pathology 1.
Option c) Type III rapidly progressive glomerulonephritis - This is incorrect terminology. The traditional classification system categorizes RPGN as:
- Type I: Anti-GBM disease (linear IgG)
- Type II: Immune complex-mediated
- Type III: Pauci-immune (ANCA-associated)
However, ANCA vasculitis corresponds to Type III RPGN, not what the patient "presents with" but rather what it IS classified as.
Option e) Type I rapidly progressive glomerulonephritis - As noted above, Type I RPGN refers to anti-GBM disease with linear immunofluorescence, not ANCA vasculitis 1.
Clinical Context
The diagnosis of AAV relies on combining clinical findings with laboratory tests (ANCA serology) and histopathology. About 90% of patients with small-vessel vasculitis have ANCA directed against MPO or PR3 1. The kidney biopsy remains the gold standard with diagnostic yield as high as 91.5% in GPA 1.
Critical pitfall: While ANCA serology strongly supports the diagnosis, approximately 10% of patients with clinical AAV are ANCA-negative 1. These patients are treated identically to ANCA-positive patients, and the diagnosis ultimately rests on the characteristic pauci-immune necrotizing and crescentic pattern on biopsy 2.
The biopsy provides both diagnostic confirmation and prognostic information through assessment of the proportion of normal, crescentic, and sclerotic glomeruli, as well as the degree of tubulointerstitial and vascular involvement 1.